The development of maillard reaction, and advanced glycation end product (AGE)-receptor for AGE (RAGE) signaling inhibitors as novel therapeutic strategies for patients with age-related diseases
In December 2017, glycopyrrolate (GLY) inhalation solution (Lonhala [Sunovion Pharmaceuticals, Inc., Marlborough, MA, USA]) 25 g twice daily (BID) delivered via the eFlow Closed System (CS) Nebulizer (Magnair [PARI Pharma GmbH, Starnberg, Germany]) was approved by the US Food and Drug Administration (FDA) for the long-term maintenance treatment of airflow obstruction in patients with moderate-to-very-severe COPD (referred henceforth as nebulized GLY) 6
The most common way to prevent or fix a deficiency is by getting vitamin B12 shots
This was a technology that has been out for about 20, 30 years now, but there are no good medications in the world
doi: 10.1111/j.1745-7254.2006.00379.x